Related by context. All words. (Click for frequent words.) 71 Cardiovascular Outcomes 70 Cardiovascular Risk Factors 70 Stroke Risk 70 Cardiovascular Events 69 Breast Cancer Recurrence 69 Venous Thromboembolism 69 Subgroup Analysis 68 Postmenopausal Women 68 Cholesterol Levels 68 Intervention Trial 67 Cognitive Function 67 Cognitive Impairment 67 Diabetes ACCORD 67 Ischemic Stroke 67 Aggressive Reduction 67 Insulin Resistance 67 Combination Treatment 67 Inflammatory Markers 67 Disease Progression 67 Cholesterol Levels SPARCL 67 Breast Cancer Risk 67 Antihypertensive 67 Insulin Sensitivity 67 Calcium Intake 67 Glycemic Control 66 Depressive Symptoms 66 Complications Trial 66 Relapsing Multiple Sclerosis 66 Chronic Heart Failure 66 Gestational Diabetes 66 Heart Failure Patients 66 Statin Therapy 66 Pooled Analysis 66 Coronary Artery Calcium 66 Diabetic Patients 66 Patient Outcomes 66 Recurrent Stroke 66 Meta Analysis 66 Platelet Inhibition 66 Lipid Lowering Treatment 65 Fracture Risk 65 Acute Myocardial Infarction 65 Septic Shock 65 Sudden Cardiac Death 65 C Reactive Protein 65 Thyroid Hormone 65 Metastatic Prostate Cancer 65 Acute Coronary Syndromes 65 STRIDE PD 65 Bone Mineral Density 65 Severe Sepsis 65 Gene Mutation 65 Antidepressant Use 65 Nonalcoholic Fatty Liver Disease 65 Controlled Trial 65 LDL Cholesterol 65 Predict Risk 65 Mortality Risk 65 Overactive Bladder 65 Myocardial Infarction 65 Oral Fingolimod 65 Resistant Hypertension 65 Hypertensive Patients 64 Allergic Rhinitis 64 Randomized Controlled Trials 64 Stent Thrombosis 64 Iron Deficiency 64 Cognitive Decline 64 Invasive Breast Cancer 64 Carotid Stenting 64 Knee Osteoarthritis 64 Lipid Levels 64 Preterm Delivery 64 Long Term Outcomes 64 Endothelial Function 64 Coronary Heart Disease 64 Diabetic Nephropathy 64 Tiotropium 64 Monotherapy 64 Patients Receiving 64 Artery Disease 64 Severe Asthma 64 HYVET 64 Kidney Function 64 Breast Cancer Treatment 64 Ischemic Heart Disease 64 Rheumatoid Arthritis Patients 64 Newly Diagnosed Multiple Myeloma 64 Myocardial Ischemia 64 Prostate Cancer Risk 63 Survival Rates 63 Statistically Significant 63 Benign Prostatic Hyperplasia 63 Alcohol Consumption 63 Critically Ill Patients 63 Diabetes Mellitus 63 Colorectal Adenomas 63 Thromboembolism 63 Pioglitazone 63 HDL Cholesterol 63 Breast Density 63 Cardiac Resynchronization 63 Preterm Birth 63 Gastric Cancer 63 Dyslipidemia 63 Non Alcoholic Fatty 63 Renal Cell Carcinoma 63 Lowers Risk 63 Lung Cancer Risk 63 Unfractionated Heparin 63 Therapeutic Effects 63 Insulin Therapy 63 Prostate Cancer Prevention 63 Hypercholesterolemia 63 Thrombolysis 63 Postmenopausal 63 Prostate Cancer Patients 63 Asthma Symptoms 63 Ischaemic 63 Psychiatric Disorders 63 Levels Linked 63 Chronic Myeloid Leukemia 63 Major Depressive Disorder 63 Microalbuminuria 63 Vascular Disease 63 Gender Differences 63 Treating Chronic 63 Hip Fractures 63 Cardiovascular Mortality 63 Acute Pancreatitis 63 Surgical Treatment 63 Randomized Study 63 Genetic Variants 63 Prostate Cancer Screening 63 Hemodialysis Patients 63 Genetic Variation 63 Coronary Disease 62 ACE Inhibitors 62 Colorectal Cancer Risk 62 Controlled Study 62 Prospective Randomized 62 Insulin Glargine 62 Newly Diagnosed 62 Ischemic 62 Colorectal Cancer Patients 62 Fibromyalgia Pain 62 Lung Cancer Survival 62 Hyperlipidemia 62 Ovarian Cancer Screening 62 Hospital Acquired Pneumonia 62 Malignant Glioma 62 Hormone Receptor Positive 62 Patients Undergoing 62 Juvenile Idiopathic Arthritis 62 ST Segment Elevation 62 Bone Fractures 62 Improve Outcomes 62 Adenoma Prevention 62 Reduced Risk 62 Randomized Controlled 62 Placebo Controlled Study 62 Urinary Incontinence 62 Acute Ischemic Stroke 62 Cardiotoxicity 62 Premature Infants 62 Hormone Therapy 62 Shows Efficacy 62 Beta Blockers 62 Vitamin D Levels 62 Novel Mechanism 62 Improves Survival 62 Antiplatelet Therapy 62 Obesity Linked 62 dysglycemia 62 Hospitalized Patients 62 Chronic Kidney Disease 62 Statin Drugs 62 Liver Failure 62 Blood Pressure Drugs 62 Lung Function 62 Aortic Stenosis 62 Randomized Double blind 62 Antipsychotic Medications 62 Systolic Hypertension 62 Menopausal Symptoms 62 Cardiovascular Disease Risk 62 Vitamin D Deficiency 62 Investigational Drug 62 Systematic Review 62 Advanced Melanoma 62 Relapsing Remitting Multiple Sclerosis 62 HIV HCV coinfected 62 COPD Exacerbations 62 Appears Safe 62 Cholesterol Drugs 62 Menopausal Women 62 Multiple Myeloma Patients 62 Clinical Outcome 62 Diabetes Complications 62 Cognitive Problems 62 Effective Treatments 62 Vitamin D Supplementation 62 Bipolar Depression 62 Anticoagulation 62 Obese Patients 62 Salt Intake 62 Nicotine Addiction 62 Hepatotoxicity 62 Solid Tumors 62 Prevent Heart 61 Stem Cell Transplants 61 Thiazolidinediones 61 Hepatocellular Carcinoma 61 Advanced Ovarian Cancer 61 Pre Eclampsia 61 Acute Heart Failure 61 Clinical Trial Results 61 Prognostic Factors 61 Reduce Cardiovascular 61 Randomized Controlled Trial 61 Renal Function 61 Antibiotic Use 61 Suicidal Behavior 61 Glucose Levels 61 Cancer Prevention ATBC 61 Prehypertension 61 Long Term Efficacy 61 Demonstrated Significant 61 Relapsed Multiple Myeloma 61 subclinical atherosclerosis 61 Laryngeal Cancer 61 Treatment Naive Patients 61 Acute Coronary Syndrome 61 Gene Linked 61 Lung Cancer Patients 61 Improve Survival 61 T1DM 61 Obese Teens 61 Drug Shows Promise 61 Diabetic Retinopathy 61 Infarction 61 Slow Progression 61 SORT OUT III 61 Lung Cancer Trial 61 Genes Linked 61 Chronic Constipation 61 Advanced Prostate Cancer 61 Premenopausal Women 61 Elderly Patients 61 Treatment Outcome 61 Epilepsy Drug 61 Heart Failure 61 Suicidal Ideation 61 Hip Fracture 61 Kidney Failure 61 Nicotine Dependence 61 Unstable Angina 61 Chronic Hepatitis C 61 Multicenter Randomized 61 Proteinuria 61 Proves Effective 61 Dementia Risk 61 Secondhand Smoke Exposure 61 Ranolazine 61 Fatty Liver Disease 61 Gene Variant 61 Acute Decompensated Heart Failure 61 Sleep Disturbances 61 Prognostic Value 61 Dietary Fat 61 Malignant Melanoma 61 Prostate Biopsy 61 Blood Cholesterol 61 Restless Legs 61 Decompensated Heart Failure 61 Metabolic Syndrome 61 Improves Outcomes 61 Pregnancy Linked 61 Breast Cancers 61 Combination Therapy 61 Renal Disease 61 Antiretroviral Therapy 61 Antipsychotic 61 Previously Treated 61 Dietary Modification Trial 61 Multicenter Double 61 Inhaled Steroids 61 Antiplatelet 61 Beta Blocker 61 Rheumatoid Arthritis RA 61 Metastatic Colorectal Cancer 61 Lung Cancers 61 Systolic Blood Pressure 61 Rectal Cancer 61 Radical Prostatectomy 61 Polycystic Ovary Syndrome 61 Risk Stratification 61 Left Ventricular 61 Postmarketing 61 Statin Use 61 Prostate Cancer Treatment 61 Survival Benefit 61 Prostate Cancer Survival 61 Lipid Lowering 61 Visceral Fat 61 Osteoarthritis Patients 61 Brain Function 61 Impaired Glucose Tolerance 61 Infected Patients 61 Liver Damage 61 Rotavirus Vaccine 60 Pulmonary Arterial Hypertension 60 Double Blind Placebo 60 Prediabetes 60 Valsartan 60 Drug Combo 60 Percutaneous Coronary Intervention 60 Overweight Obese 60 Randomized Double Blind Placebo 60 Subtypes 60 Colorectal Cancers 60 Endometrial Cancer 60 Ventricular Arrhythmias 60 Carotid Endarterectomy 60 Nesiritide 60 Randomized Phase 60 Osteoporosis Drugs 60 Fondaparinux 60 PLCO 60 Prevent Stroke 60 Folic Acid Supplements 60 Orthostatic Hypotension 60 Genetic Variant 60 Glucose Metabolism 60 Colorectal Cancer Screening 60 Inflammatory Response 60 Gene Mutations 60 platelet reactivity 60 Bone Metastases 60 Brain Atrophy 60 Comorbidities 60 Severely Obese 60 Asthma Treatment 60 Ramipril 60 Bloodstream Infections 60 Patients Treated With 60 Symptom Relief 60 Antipsychotic Drugs 60 Early Diagnosis 60 Treatment Naive 60 Vitamin D Linked 60 Clopidogrel 60 EURIDIS 60 Signaling Pathways 60 Enoxaparin 60 Genetic Markers 60 Aggressive Prostate Cancer 60 Nilotinib 60 Randomized Clinical Trial 60 Birth Weight 60 Cause Mortality 60 Clinical Outcomes 60 hypovitaminosis D 60 systolic hypertension 60 Diabetic Kidney Disease 60 Chronic Liver Disease 60 Childhood Asthma 60 Prolongs Survival 60 Hyperkalemia 60 Generalized Anxiety Disorder 60 Tumor Growth 60 Adjuvant Chemotherapy 60 T2DM 60 serum urate levels 60 Brain Shrinkage 60 Gastric Bypass Surgery 60 Observational Studies 60 ACE Inhibitor 60 Psychiatric Illness 60 Better Outcomes 60 Low Density Lipoprotein Cholesterol 60 Antipsychotic Drug 60 Smoking Linked 60 Blood Glucose 60 Stomach Cancer 60 Adjuvant Therapy 60 Gene Variation 60 Medication Errors 60 Nonalcoholic Steatohepatitis 60 Myelodysplastic Syndromes 60 elevated LDL cholesterol 60 Homocysteine 60 Clostridium difficile Infection 60 AA Amyloidosis 60 Val HeFT 60 Chronic Insomnia 60 Adenoma 60 Prostate Screening 60 Randomized Double Blind 60 Increases Risk 60 Physical Function 60 Uric Acid 60 Pivotal Phase 60 antihypertensive therapy 60 Autologous Stem Cell Transplantation 60 Pediatric Patients 60 fasting glucose levels 60 Coronary Artery Bypass Graft 60 Anxiety Depression 60 Breast Cancer Patients 60 NOMID 60 Double Blind Randomized 60 Stop Hypertension DASH diet 60 Diagnostic Criteria 60 Alpha Tocopherol Beta Carotene 60 Hepatitis C Virus 60 Non Inferiority 60 Combo Therapy 60 Genetic Variations 60 Phase III Clinical Trial 60 NIDDM 60 urate levels 60 Anticoagulant 60 abdominal adiposity 60 Panic Disorder 60 Bone Fracture 60 IDDM 60 Outpatient Setting 60 Is Well Tolerated 60 VADT 60 Improved Survival 60 Radiation Dose 60 Advanced Colorectal Cancer 60 Increased Risk 60 Treatment Outcomes 59 ACCORD Lipid 59 Phase 2b Clinical Trial 59 Epilepsy Drugs 59 RIO Diabetes 59 Bare Metal Stents 59 Reduces Mortality 59 Hematologic 59 Sexual Function 59 Castration Resistant Prostate Cancer 59 Drug Prevents 59 Estrogen Therapy 59 Medication Adherence 59 Moderate Drinking 59 Clinical Efficacy 59 Epileptic Seizures 59 Alcohol Intake 59 Digital Mammographic Imaging 59 Respiratory Infections 59 Emerging Therapies 59 Follicular Lymphoma 59 paroxetine Paxil 59 evaluating mipomersen 59 Contraceptive Use 59 Illicit Drug Use 59 Thrombotic 59 Acute Myocardial 59 Fecal Incontinence 59 Testosterone Levels 59 Adalimumab 59 Breast Cancer Metastasis 59 Randomized Trials 59 Predict Prostate Cancer 59 Sustained Reduction 59 Adenomas 59 Atopic Dermatitis 59 Chronic Inflammation 59 Childhood Vaccinations 59 Renal Cancer 59 Localized Prostate Cancer 59 Malignancies 59 Prophylactic Treatment 59 ATACAND 59 Blood Glucose Levels 59 Viral Suppression 59 Valvular Heart Disease 59 Lung Injury 59 Functional Outcomes 59 Hyperuricemia 59 Diabetes Interventions 59 Anemia Drug 59 Hemorrhagic Stroke 59 Sustained Efficacy 59 Renal Impairment 59 ALLHAT 59 Sleep Duration 59 Organ Rejection 59 Patients Treated 59 Treatment Reduces 59 Gout Drug 59 Restenosis 59 See CLINICAL PHARMACOLOGY 59 Sexual Satisfaction 59 Genes Associated 59 Androgen Deprivation Therapy 59 Adverse Effects 59 Fibrates 59 Randomized Evaluation 59 Antidepressants Linked 59 serum leptin 59 Ezetimibe 59 Pesticide Exposure 59 Fungal Infections 59 atherogenic dyslipidemia 59 Autoantibodies 59 Randomized Phase II 59 Brain Scans 59 Breast Carcinoma 59 longitudinal cohort study 59 Erectile Dysfunction Drug 59 Slows Progression 59 Adjuvant Treatment 59 Ovarian Cancer Risk 59 Diastolic Heart Failure 59 Protein Linked 59 HbA1c levels 59 Gum Disease 59 dapagliflozin plus 59 Coronary Artery Disease 59 Clinical Antipsychotic Trials 59 Inflammatory Arthritis 59 Suicidality 59 Adverse Events 59 Multicenter Study 59 Multicenter Trial 59 Diabetic Foot Ulcer 59 Carotid Intima Media 59 Pregnancy Outcomes 59 homocysteine concentrations 59 Main Outcome Measure 59 folate deficiency 59 Arrhythmias 59 Prognostic Significance 59 Cholesterol Drug 59 Cholesterol Lowering Drug 59 Chronic Lymphocytic Leukemia 59 Demonstrates Efficacy 59 Rosuvastatin 59 serum folate concentrations 59 Placebo Controlled Trial 59 Preterm Infants 59 Intervention Effectiveness 59 Aspirin Therapy 59 Edge STudy 59 Multicenter Automatic Defibrillator Implantation 59 Aromatase Inhibitors 59 Preterm Labor 59 Stable Coronary Artery 59 Investigational Agent 59 Investigational Compound 59 subclinical hypothyroidism 59 Dendritic Cells 59 serum triglycerides 59 Intracerebral Hemorrhage 59 Meningococcal Disease 59 Nutritional Status 59 Hypertensive 59 Investigational Treatment 59 Prostate Lung Colorectal 59 insulin detemir 59 Pivotal Phase III 59 Migraine Headaches 59 Prevent Breast Cancer 59 Dose Response 59 Cardiac Function 59 Left Ventricular Hypertrophy 59 Coronary Revascularization 59 Muscle Function 59 AIM HIGH 59 Hormone Refractory Prostate Cancer 59 Risk Behavior 59 Adiposity 59 Hormone Replacement 58 Showed Significant 58 Antiepileptic Drugs 58 Myocardial Perfusion 58 ADHD Medication 58 Oral Formulation 58 Beneficial Effects 58 Prospective Cohort Study 58 Diabetic Foot Ulcers 58 Increased Mortality 58 Cardiac Biomarkers 58 Anticancer Drugs 58 Versus Placebo 58 Gene Variants 58 Adult ADHD 58 Prostatectomy 58 oral antidiabetic medication 58 Outcome Measures 58 Immunologic 58 Osteoporosis Drug 58 Prolonged Survival 58 Ambulatory Blood Pressure 58 Therapeutic Potential 58 Cancer Recurrence 58 Metastatic Renal Cell Carcinoma 58 Cyclooxygenase 2 58 Circulating Tumor Cells 58 Periodontal Disease 58 Intervention Trial GAIT 58 Pediatric Asthma 58 Bipolar Mania 58 Cerebrospinal Fluid 58 Partial Onset Seizures 58 Cancer Therapies 58 Calcium Vitamin D 58 Complication Rates 58 Nymox NX 58 Observational Study 58 Pharmacologic 58 Insulin Secretion 58 Chemotherapeutic Agents 58 MADIT II 58 ONTARGET 58 Hypoglycaemia 58 Socioeconomic Status 58 Metabolic Disorder 58 Antidepressant Drug 58 Node Negative 58 Evaluation WISE 58 ACCORD Eye 58 Nicotine Vaccine 58 hypercholesterolaemia 58 Study Evaluating 58 Stress Induced 58 Drug Coated Stents 58 Sexual Desire 58 Oral Cavity 58 Pneumococcal Vaccine 58 atherothrombotic disease 58 ExTRACT TIMI 58 serum uric acid 58 Bipolar Disorders 58 Chronic Renal Failure 58 Celecoxib APC trial 58 metabolic syndrome MetS 58 Left Ventricular Dysfunction 58 Skin Lesions 58 RE LY ® 58 CALERIE 58 Renal Insufficiency 58 SPARCL 58 Anticoagulants 58 Secondary Hyperparathyroidism 58 Breast Tumors 58 Blood Pressure Drug 58 Node Positive 58 Lowering Blood Pressure 58 Molecular Basis 58 Anticancer Activity 58 diabetes mellitus 58 juvenile idiopathic arthritis 58 Dementia Patients 58 Genes Predict 58 Clostridium difficile Associated 58 Neoadjuvant Chemotherapy 58 Gastrointestinal Disorders 58 Virus Infection 58 macrovascular disease 58 STEP BD 58 Implantable Device 58 Fixed Dose 58 Bile Acid 58 Antiviral Drugs 58 Renal Tumors 58 Postherpetic Neuralgia 58 Ventricular Tachycardia 58 NATRECOR R 58 Phase 2b Study 58 Intervention Effectiveness CATIE 58 Bone Density 58 Meets Primary Endpoint 58 Bladder Cancer 58 Zoledronic Acid 58 Reduce Mortality 58 Iron Overload 58 Clinical Practice Guideline 58 diabetes mellitus DM 58 Hip Fracture Risk 58 Lipodystrophy 58 Calcium Supplements 58 Viral Load 58 Cancer Treatments 58 Treatment Naive HIV 58 CAMMS# 58 elevated triglycerides 58 CLOTS 58 Skeletal Muscle 58 Prostate Specific Antigen 58 Tolerability 58 Uterine Fibroids 58 Nocturia 58 Blood Thinner 58 Asthma Attacks 58 Ovarian Cancer Patients 58 Migraine Headache 58 Short Stature 58 Epoetin Alfa 58 Autoimmune Disease 58 serum phosphate 58 Endarterectomy 58 Phase III Trial 58 Male Fertility 58 NCT# ClinicalTrials.gov 58 Plus Ribavirin 58 Blood Pressure Lowering 58 Antipsychotics 58 Cognitive Deficits 58 Placebo Controlled 58 GISSI 58 Myeloma Patients 58 Cost Effectiveness 58 Inhaled Corticosteroids 58 Blood Pressure 58 Regimens 58 Enlarged Prostate 58 Genes Identified 58 Randomised Controlled Trial 58 Early Lung Cancer 58 Acne Drug 58 hemoglobin A1c HbA1c 58 Prostate Cancer Recurrence 58 Low Dose 58 Lower Blood Pressure 58 TNF Blockers 58 Esophageal Cancer 58 Protease Inhibitors 58 Postmenopausal Osteoporosis 58 Breast Tumor 58 Stress Hormone 58 postoperative mortality 58 hyperglycaemia 58 Blood Cancers 58 Migraine Pain 58 Heart Disease 58 Novel Oral 58 baseline HbA1c 58 Multicenter 58 Treating Depression 58 angiotensin II receptor blockers 58 Experimental Vaccine 58 venous thromboembolic disease 58 Premature Birth 58 Prospective Multicenter 58 Phase III Pivotal Trial 58 Renal Artery 58 Study Shows Promise 58 Adolescent Obesity 58 dyslipidaemia 58 Adjuvant Breast Cancer 58 Dialysis Outcomes 58 Sleep Disordered Breathing 58 Dasatinib 58 Bivalirudin 58 serum calcium levels 58 Substance Use 58 ER Visits 58 Nephropathy 58 glycated hemoglobin 58 Antitumor Activity 58 colorectal adenoma 58 High Blood Pressure 58 Virus Linked 58 Stenting 58 Breast Cancer Incidence 58 serum IGF 58 Exacerbations 58 Genetic Tests 58 Prolongs Life 58 Demonstrates Positive 58 subanalysis 58 Carotid Revascularization Endarterectomy vs. 58 Significantly Improved 57 gallstone disease 57 Prostate Cancers 57 Non Alcoholic Steatohepatitis 57 Lipoprotein 57 Breast Cancer Survival 57 Colorectal Screening 57 hypercholesterolemic patients 57 HCV Protease Inhibitor 57 Atherosclerotic 57 Hemoglobin A1c 57 Skin Cancers 57 Progressive Multifocal Leukoencephalopathy 57 BRIM3 57 Phase IIb Trial 57 Platelet Aggregation 57 Predisposition 57 Hyperglycemia 57 Preclinical Models 57 Demonstrates Potent 57 Rheumatoid 57 elevated CRP 57 Pancreatic Cancer Risk 57 Dual Antiplatelet Therapy 57 Blood Flow 57 GISSI HF 57 Passive Smoking 57 Bowel Disease 57 Patient Populations 57 Mortality Rate 57 Elevated Levels 57 Leukemias 57 Shows Promising 57 Diagnosis Treatment 57 Drug Fails 57 Respiratory Illness 57 Risedronate 57 Diuretic 57 RE LY 57 Study Showed 57 Radiofrequency Ablation 57 Adult Onset 57 Blood Clot Risk 57 Asymptomatic 57 Bevacizumab 57 Infarct 57 Protease Inhibitor 57 Heart Failure Risk 57 Hypotension 57 Placebo Effect 57 Cutaneous T 57 Rheumatic Fever 57 MMR Vaccine 57 Heartburn Drugs 57 Metabolic Disease 57 Atorvastatin Evaluation 57 microalbuminuria 57 Poorly Controlled 57 HIV Infection 57 Celebrex celecoxib 57 Acute Stroke 57 Stem Cell Treatment 57 Randomized Placebo Controlled 57 HCV SPRINT 57 Pharmacodynamics 57 multicenter multinational 57 Coronary Angiography 57 Neuroprotective Effects 57 Candesartan 57 Inflammatory Diseases 57 Novel Method 57 Rheumatoid Arthritis 57 relapsed MM 57 fasting insulin 57 Heterozygous Familial Hypercholesterolemia 57 Child Mortality 57 Naive Patients 57 Generalized Anxiety Disorder GAD 57 Severe Acne 57 Patients Suffering 57 Glucosamine Chondroitin Arthritis 57 Autoimmune Disorders 57 CALGB # [001] 57 elevated ALT 57 Tumor Progression 57 Treatment Shows Promise 57 Interpersonal Psychotherapy 57 elevated triglyceride levels 57 Anti Tumor Activity 57 glycosylated hemoglobin HbA1c 57 Dialysis Patients 57 Lung Cancer Screening 57 Advanced Renal Cell 57 Antitumor 57 Attack Trial ALLHAT 57 Bare Metal Stent 57 Cognitive Abilities 57 Screening Mammography 57 Saturated Fat 57 nulliparous women 57 Excessive Sweating 57 Cancer Incidence 57 Maternal Deaths 57 extrapyramidal symptoms 57 serum lipids 57 Autoimmune Diseases 57 Endocrine Therapy 57 Venous Thrombosis 57 Glycemia 57 recurrent venous thromboembolism 57 Diabetic Neuropathy 57 Therapy Improves 57 Unresectable 57 Endothelial Dysfunction 57 Hospitalization Rates 57 Sleep Disturbance 57 Preterm Births 57 JAK Inhibitor 57 Congenital Heart Disease 57 prospective observational cohort 57 Antisocial Behavior 57 Cervical Disease 57 carotid atherosclerosis 57 Minimally Invasive Treatment 57 Anaemia 57 Randomized Comparison 57 venlafaxine Effexor 57 Calorie Intake 57 Molecular Weight Heparin 57 Watchful Waiting 57 Certain Cancers 57 Genital Herpes 57 Asthma Medication 57 Trandolapril 57 Tyrosine Kinase Inhibitor 57 Single Dose 57 Viral Infections 57 Non Responders 57 Test Detects 57 Vildagliptin 57 Coronary Artery 57 Transplant Patients 57 Antifungals 57 hypertensives 57 Coronary Arteries 57 Allergic Asthma 57 Aggressive Behavior 57 Respiratory Symptoms 57 dose atorvastatin 57 Ankylosing Spondylitis 57 Vaginal Gel 57 Estrogen Receptor 57 Immune Responses 57 spontaneous preterm delivery 57 Chronic Hepatitis B 57 Treated Patients 57 Renal Anemia 57 Complicated Skin 57 Perindopril 57 Safinamide 57 Comorbid 57 Guidelines Issued 57 Clinical Practice Guidelines 57 Well Tolerated 57 Glucose Control 57 Chronic Diseases 57 Idiopathic Pulmonary Fibrosis 57 CombAT 57 Cholesterol Lowering 57 lipid levels 57 Blind Placebo Controlled Trial 57 inflammatory biomarkers 57 Mild Cognitive Impairment 57 Stakeholder Insight 57 Blood Pressure Monitoring 57 Bucindolol 57 Cystatin C 57 Randomized Clinical Trials 57 Thyroid Cancer 57 Anti Clotting Drug 57 Genetic Mutations 57 Screening Trial 57 Sipuleucel T 57 Randomized Phase III 57 Treating Heart Failure 57 Alzheimer Disease Cooperative 57 Serious Infections 57 Desvenlafaxine Succinate 57 Clinical Evaluation 57 coronary heart 57 adenoma recurrence 57 Aliskiren 57 prospective multicentre 57 candesartan 57 Phase III Clinical Trials 57 Female Sexual Arousal 57 ST Elevation Myocardial 57 Hb A1C 57 Clinical Trial Data 57 Study Casts Doubt 57 Confirms Efficacy 57 lipid abnormalities 57 Hydroxyurea 57 Childhood Trauma 57 CHAMPION PCI 57 Epidermal Growth Factor Receptor 57 Treatment Approaches 57 Alcohol Dependence 57 Atomoxetine 57 Romantic Relationships 57 Lp PLA 2 57 Therapy Reduces 57 Demonstrate Significant 57 Cervical Dysplasia 57 Long Term Survival 57 CLARITY TIMI 57 HCV RESPOND 2 57 Angiographic 57 Natalizumab 57 Major Adverse Cardiac 57 Growth Hormone Deficiency 57 gestational diabetes mellitus